StockData
MediciNova Inc logo

MediciNova Inc (MNOV) stock

MNOVNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$1.34+0.00 (0.00%)

Close on Nov 17, 2026Market cap $65.96MP/E –Yield –

MediciNova operating margin

Operating margin is operating income as a percentage of revenue.

MediciNova's operating margin for the twelve months ending Jun 30, 2026 was -1287.4%. For fiscal 2025 it was -3242.5%, against -990.0% the year before. The highest annual figure on record is -253.0% in fiscal 2021.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-3242.5%−2252.4
FY2023Dec 31, 2023-990.0%−737.0
FY2021Dec 31, 2021-253.0%+123190.0
FY2013Dec 31, 2013-123443.0%−122079.3
FY2012Dec 31, 2012-1363.8%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 2026-554.3%+2125.6
Q1 FY2026Mar 31, 2026-1516.6%−1401.9
Q4 FY2025Dec 31, 2025-2038.0%+7567.2
Q3 FY2025Sep 30, 2025-2741.7%−2736.6
Q2 FY2025Jun 30, 2025-2679.9%–
Q3 FY2023Sep 30, 2023-114.7%–
Q3 FY2021Sep 30, 2021-9605.2%–
Q1 FY2021Mar 31, 2021-5.0%–

More MediciNova figures

See a number that looks wrong?